Products
Built multiple sets of modular, multi-functional intelligent drug automatic synthesis platform
OnePlatform Version 3.1
Keywords: synthetic equipment disposable consumables
Classification:
Synthesis Equipment
Hotline:
OnePlatform Version 3.1
Graphic Details
Version 3.1 of OnePlatform, a simple, reliably repeatable, standardized drug synthesis system, is designed for the development of complex radiolabeling processes. It features high automation, compact size, and exceptional stability, while seamlessly integrating the entire workflow of radiopharmaceutical synthesis—including radionuclide elution, quality control, separation & purification, and sterile filtration.
OnePlatform 3.1 is primarily used for 18 F, 11 C, 68 Ga, 64 Cu isotope labeling includes the following features:
● Enables the synthesis of small molecules, peptides, and protein/antibody labeling;
● High design flexibility and strong development potential;
● Modular and combinational design allows for the selection of various functional modules based on the main unit, enabling a wide range of capabilities.
The company has developed several new synthetic processes for novel radionuclide-labeled positron emission tomography tracers (such as 18 F - Safinamide, 18 F -FHBG, 18 F -MK9470 and others) have significant application value in the mechanistic research and diagnosis of major diseases such as cancer, cardiovascular and cerebrovascular disorders, and neurodegenerative conditions. The company’s core products include the design and manufacturing of advanced automated systems for radiopharmaceutical synthesis, as well as the design, synthesis, and production of PET tracers.
Previous Page
OnePlatform Version 3.2
Next Page
Related Products
Consulting
©2024 Hangzhou Jirui Technology Co., Ltd. All Rights Reserved